HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jonas Björk Selected Research
Jonas Björk Research Topics
Disease
11
Hypersensitivity (Allergy)
01/2022 - 01/2004
8
Chronic Renal Insufficiency
01/2022 - 06/2012
8
Neoplasms (Cancer)
09/2019 - 10/2004
4
COVID-19
10/2022 - 09/2021
4
Cardiovascular Diseases (Cardiovascular Disease)
11/2020 - 11/2009
4
Body Weight (Weight, Body)
08/2014 - 12/2006
3
Dermatitis
01/2022 - 06/2007
3
Obesity
09/2019 - 10/2004
3
Kidney Diseases (Kidney Disease)
01/2019 - 10/2016
3
Acute Kidney Injury (Acute Renal Failure)
06/2016 - 12/2015
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2010 - 10/2004
2
Infections
02/2022 - 01/2022
2
Eczema
09/2021 - 01/2019
2
Surgical Wound Infection
04/2021 - 01/2020
2
Myocardial Infarction
04/2021 - 04/2016
2
Surgical Wound
05/2020 - 01/2020
2
Overweight
01/2020 - 07/2017
2
Chest Pain (Chest Pains)
04/2016 - 03/2009
2
Tuberculosis (Tuberculoses)
01/2014 - 01/2013
2
Muscular Atrophy (Muscle Atrophy)
04/2010 - 01/2009
2
Stroke (Strokes)
01/2010 - 11/2007
1
Skin Diseases (Skin Disease)
09/2021
1
Appendicitis
04/2021
1
Wounds and Injuries (Trauma)
01/2020
1
Cryptorchidism (Undescended Testes)
01/2020
1
Parkinson Disease (Parkinson's Disease)
01/2020
1
Hematologic Neoplasms (Hematological Malignancy)
01/2019
1
Food Hypersensitivity (Food Allergy)
01/2019
1
Atherosclerosis
01/2019
1
Rhinitis
01/2019
1
Sepsis (Septicemia)
04/2017
1
Critical Illness (Critically Ill)
04/2017
1
Septic Shock (Toxic Shock Syndrome)
04/2017
1
Pain (Aches)
01/2017
1
Chronic Pain
01/2017
1
Bronchitis
10/2013
1
Bronchiolitis
10/2013
1
Asthma (Bronchial Asthma)
10/2013
1
Chromosome Aberrations (Chromosome Abnormalities)
01/2013
1
Atopic Dermatitis (Atopic Eczema)
01/2013
1
Pruritus (Itching)
01/2013
1
Lymphopenia (Lymphocytopenia)
01/2013
1
ST Elevation Myocardial Infarction
02/2012
1
Hepatitis B
01/2012
1
Inflammation (Inflammations)
04/2011
Drug/Important Bio-Agent (IBA)
10
Creatinine
IBA
01/2022 - 01/2009
4
Proteins (Proteins, Gene)
FDA Link
01/2019 - 05/2009
4
Cystatin C
IBA
01/2018 - 01/2009
4
Contrast Media
IBA
06/2016 - 04/2008
3
Allergens
IBA
01/2019 - 06/2007
3
Growth Hormone (Somatotropin)
IBA
08/2010 - 10/2004
3
Hormones (Hormone)
IBA
11/2009 - 10/2004
2
Vaccines
IBA
02/2022 - 01/2022
2
Troponin T (Troponin T1)
IBA
04/2021 - 04/2016
2
HDL Cholesterol
IBA
09/2019 - 08/2010
2
diphenylguanidine
FDA Link
07/2019 - 09/2018
2
Troponin
IBA
01/2019 - 04/2016
2
Pharmaceutical Preparations
IBA
10/2013 - 01/2012
2
Aluminum
IBA
01/2013 - 01/2009
2
iodixanol (Visipaque)
FDA Link
07/2012 - 04/2008
2
Gold
IBA
03/2009 - 09/2008
1
BNT162 Vaccine
IBA
02/2022
1
N-(2-cyanoethylene)urea (BA 1)
IBA
01/2022
1
N-methyl-valyl-amiclenomycin (BA 2)
IBA
01/2022
1
Limonene
IBA
01/2022
1
Terpenes (Terpenoids)
IBA
01/2022
1
linalool
IBA
01/2022
1
Hand Sanitizers
IBA
09/2021
1
Soaps (Soap)
IBA
09/2021
1
Calcium
IBA
11/2020
1
Hexachlorobenzene (HCB)
IBA
01/2020
1
perfluoro-n-nonanoic acid
IBA
01/2020
1
perflexane (perfluorohexane)
FDA Link
01/2020
1
perfluorooctane
IBA
01/2020
1
perfluorooctanoic acid
IBA
01/2020
1
Immunoglobulin E (IgE)
IBA
01/2019
1
Endocrine Disruptors
IBA
07/2017
1
Pain-Free
IBA
01/2017
1
Appetite Depressants (Anorectics)
IBA
10/2016
1
omega-Chloroacetophenone (Mace)
IBA
04/2016
1
Antigens
IBA
01/2013
1
Biomarkers (Surrogate Marker)
IBA
01/2013
1
Phytohemagglutinins
IBA
01/2013
1
iomeprol
IBA
07/2012
1
Irritants (Vesicants)
IBA
04/2012
1
Ethylene Oxide (Oxirane)
IBA
01/2011
Therapy/Procedure
3
Therapeutics
01/2013 - 11/2009
3
Stents
03/2009 - 06/2007
2
Length of Stay
04/2021 - 04/2017
2
Negative-Pressure Wound Therapy
05/2020 - 01/2020
2
Vascular Surgical Procedures
05/2020 - 01/2020
2
Drug Therapy (Chemotherapy)
11/2005 - 10/2004
1
Long-Term Care
10/2022
1
Personal Protective Equipment
09/2021
1
Appendectomy
04/2021
1
Activities of Daily Living (ADL)
01/2020
1
Orchiopexy
01/2020
1
Art Therapy
01/2014
1
Immunotherapy
01/2013
1
Percutaneous Coronary Intervention
02/2012